Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > NASH epidemic
View:
Post by scarlet1967 on Jul 27, 2021 10:05am

NASH epidemic

I did mention while ago the agencies should lower the bar for a future approved drug before the conditions become epidemic. Now this....
https://www.sciencedirect.com/science/article/abs/pii/S0016508521007496
Comment by Wino115 on Jul 27, 2021 10:32am
Interesting, Stephen Harrison Now lists Theratech as a consulting client.  Hs the numero uno guy in US so if involved in discussions around a partnership would be a plus.  Obviously Gronspoon is top dog on the science, but doesn't hurt to have Harrison and Loomba involved.   I'm still in the category of it taking a while to partner and upfront not being that attractive ...more  
Comment by qwerty22 on Jul 27, 2021 12:26pm
That is more than interesting.
Comment by qwerty22 on Jul 27, 2021 12:29pm
If they did the picture would brighten for thtx but they haven't and all the signals point to it not happening before 2022. But they must see all the failure to get drugs thru the process and that must concern them. It's one of their remits to provide paths to approval for good drugs.  
Comment by jakayo4 on Jul 27, 2021 12:30pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities